RA
BRLI

Royce & Associates’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Royce & Associates’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-201,200
Closed -$8.3M – 1264
2015
Q2 		$8.3M Sell
201,200
-87,900
-30% -$3.15M 0.04% 605
2015
Q1 		$10.2M Buy
289,100
+82,800
+40% +$2.8M 0.04% 566
2014
Q4 		$6.63M Sell
206,300
-74,600
-27% -$2.16M 0.02% 721
2014
Q3 		$7.88M Sell
280,900
-23,434
-8% -$714K 0.03% 684
2014
Q2 		$9.2M Buy
304,334
+45,400
+18% +$1.25M 0.03% 698
2014
Q1 		$7.17M Buy
258,934
+143,334
+124% +$3.75M 0.02% 780
2013
Q4 		$2.95M Hold
115,600
– – 0.01% 999
2013
Q3 		$3.45M Sell
115,600
-62,400
-35% -$1.74M 0.01% 942
2013
Q2 		$5.12M Buy
+178,000
New +$4.9M 0.02% 839

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Royce & Associates's BRLI Position: Q3 2015 in Review

Royce & Associates sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 201,200 shares — an estimated $8.3M sold.

Royce & Associates first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $10.2M in Q1 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Royce & Associates reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Royce & Associates sold 201,200 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $8.3M.
  • Royce & Associates first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Royce & Associates's BIO-REFERENCE LABS INC-NEW- position peaked at $10.2M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Royce & Associates's 13F filing for Q3 2015, filed 12 Nov 2015.